Subjects - Business

When doing medical billing, you'd think with all the payer records being sent, second only to service line records, there wouldn't be as many probl

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ems with denied claims because of missing information. Such is not the case. In this article, we're going to review the third and last payer reco

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

d, which is the DA2 record.

DA2 field 1, positions 1 - 3, is the record type which needs to be filled in with DA2 or the claim will not be paid.

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

A2 field 2, positions 4 - 5, is the sequence number. Because there can be up to three DA2 records, each one has to have a sequence number for prim

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ry, secondary and tertiary, designated DA2-01, DA2-02 and DA2-03.

DA2 field 3, positions 6 - 22, is the patient ID. This number must match the pa

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ient ID numbers transmitted in the CA0 and all the other D records in this claims file for that patient.

DA2 fields 4, 5, 6, 7 and 8, positions 23

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

- 113, is the patient's address, which includes two fields for street address, city, state and zip code. All fields are required except for addres

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

field two.

DA2 field 9, positions 114 - 123, is the patient's telephone number. This number must be entered without any spaces, dashes or any ot

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

er special characters.

DA2 field 10, positions 124 - 131, is the insured's retirement date. This is the date when the insured retired from work.

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

This needs to be filled in because benefits sometimes change when a person retires from a company. In many cases, benefits are decreased. If of c

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

urse the insured is still working, this is left blank.

DA2 field 11, positions 132 - 139, is the retirement date of the insured's spouse. Same ex

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

planation as above if the spouse is responsible for the insurance and not the patient.

DA2 field 12, positions 140 - 172, is the insured's employe

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

name. If the insured is still working, then the name of the employer needs to go here.

DA2 fields 13 - 17 positions 173 - 263, is the insured's

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

mployer address. A special note should be made about these fields because many people, in today's marketplace, work for employers where their actu

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

l work address is not the same as the address of the employer's home office. If you're wondering why this matters, it's very simple. In some case

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

, it is the home office address that the insurance information is filed under. If the patient gives the address of the location where they work, s

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ould it be different from the home office, the claim will be denied because the payer won't find the insured information under the address given.

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

A2 field 18, positions 264 - 275, is the insured employer ID. This is not the ID of the employee but the ID of the employer, which is the ID assoc

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ated with the insurance they are subscribed to. This is often another area of confusion.

DA2 field 19, positions 276 - 320, is filler national an

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

must be left blank.

This concludes the last of the three payer records for medical billing of claims electronically using NSF 3.01 specifications

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.subjects.org.ua/article/21816/subjects-Medical-Billing--DA2-Record.html">Medical Billing - DA2 Record</a>

BB link (for phorums):
[url=http://www.subjects.org.ua/article/21816/subjects-Medical-Billing--DA2-Record.html]Medical Billing - DA2 Record[/url]

As a human resources professional or business owner, you face many challenges during the hiring process, from sorting through stacks of job applicant r?sum?s to making an attractive offer to the one person you believe best matches the specifications of your open position's job description.

Using a coastal vacation call center gives travel agents more time to prospect for new business. With thousands of people beginning a travel agent business each year, business owners need this kind of support.

Coil, or spiral, binding is the most familiar type of binding technology that may be usually seen in blank notebooks. Binding is a procedure by which pages and cover of a book are bound together by using a ribbon sewn along an edge of a book for support or beautification. Generally, bound documents last longer than unbound documents.

Tags

Links

Subjects - Medical Billing - DA2 Record

Related Articles: